Literature DB >> 21771730

Review on the current use of antipsychotic drugs in children and adolescents.

Noor B Almandil1, Ian C K Wong.   

Abstract

Antipsychotic (neuroleptic) drugs are used in the treatment of various psychiatric disorders in children and adolescents. There is a lack of information about the efficacy and safety of antipsychotics in young people. Much of the information available is extrapolated from adult studies; in particular, little is known about the long-term effects of these drugs on the development of the central nervous system. Over the last two decades, typical antipsychotics have largely been replaced by atypical antipsychotics. With this increase in use of atypical antipsychotic drugs, there has been growing concern about the appropriate use of these drugs and the fact that they appear to be associated with metabolic abnormalities such as weight gain, diabetes and related cardiovascular effects. This paper provides a review of current practice and evidence based use of antipsychotic drugs in children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771730     DOI: 10.1136/archdischild-2011-300054

Source DB:  PubMed          Journal:  Arch Dis Child Educ Pract Ed        ISSN: 1743-0585            Impact factor:   1.309


  15 in total

1.  The role of co-occurring disruptive behavior in the clinical presentation of children and adolescents with anxiety in the context of autism spectrum disorders.

Authors:  Eric A Storch; Elysse B Arnold; Anna M Jones; Chelsea M Ale; Jeffrey J Wood; Jill Ehrenreich-May; Adam B Lewin; P Jane Mutch; Tanya K Murphy
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

2.  Associations between the LEP -2548G/A Promoter and Baseline Weight and between LEPR Gln223Arg and Lys656Asn Variants and Change in BMI z Scores in Arab Children and Adolescents Treated with Risperidone.

Authors:  Noor B Almandil; Rohit J Lodhi; Hongyan Ren; Frank M C Besag; David Rossolatos; Ruth Ohlsen; Caitlin Slomp; Diego L Lapetina; Giona Plazzotta; Macey L Murray; Abdulsalam A Al-Sulaiman; Paul Gringras; Ian C K Wong; Katherine J Aitchison
Journal:  Mol Neuropsychiatry       Date:  2018-10-05

3.  Trends, correlates, and disease patterns of antipsychotic use among children and adolescents in Taiwan.

Authors:  Yuan-Chang Hsu; I-Chia Chien; Happy Kuy-Lok Tan; Ching-Heng Lin; Shu-Wen Cheng; Yiing-Jenq Chou; Pesus Chou
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-05-08       Impact factor: 4.328

4.  Drugs for kids: good or bad?

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2012-09       Impact factor: 6.186

Review 5.  Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections?

Authors:  Chen Liu; Syann Lee; Joel K Elmquist
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

6.  Adult response to olanzapine or clozapine treatment is altered by adolescent antipsychotic exposure: a preclinical test in the phencyclidine hyperlocomotion model.

Authors:  Qing Shu; Gang Hu; Ming Li
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

Review 7.  Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Authors:  Jik H Loy; Sally N Merry; Sarah E Hetrick; Karolina Stasiak
Journal:  Cochrane Database Syst Rev       Date:  2017-08-09

8.  Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?

Authors:  Jing Qiao; Jun Gao; Qing Shu; Qinglin Zhang; Gang Hu; Ming Li
Journal:  Psychopharmacology (Berl)       Date:  2013-12-21       Impact factor: 4.530

Review 9.  Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.

Authors:  José María Martínez-Ortega; Silvia Funes-Godoy; Francisco Díaz-Atienza; Luis Gutiérrez-Rojas; Lucía Pérez-Costillas; Manuel Gurpegui
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-03-17       Impact factor: 4.785

Review 10.  Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.

Authors:  Noor B Almandil; Ying Liu; Macey L Murray; Frank M C Besag; Katherine J Aitchison; Ian C K Wong
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.